As your browser does not support javascript you won't be able to use all the features of the website. We strongly recommend you to enable the javascript in your old browser's settings or download a new one.

Allergan CEO expects drug industry to face pricing heat from Trump

Allergan CEO Brent Saunders prepares to give an interview on the floor of the New York Stock Exchange (NYSE) April 6, 2016.

U.S. President-elect Donald Trump could be more critical of drugmakers and their price increases than the industry expects, Allergan Inc Chief Executive Brent Saunders said on Thursday.

Saunders, speaking at the annual Forbes Healthcare Summit in New York, predicted Trump could be a "more vicious tweeter" against the drug industry than his former Democratic rival Hillary Clinton had been during the...

WhoTrades Ltd, its affiliates and partners are not responsible or liable in any manner for any Content posted on whotrades.com. WhoTrades Ltd does not endorse, support, sanction, encourage, verify, or agree with the comments, opinions, or statements of third parties displayed on or transmitted via the site. Any opinions expressed on the website as to the future direction of prices of specific investments are purely opinions, do not necessarily represent the opinion of WhoTrades Ltd, and are not guaranteed in any way. In no event will WhoTrades Ltd, its affiliates, and partners have any liability for any losses incurred in connection with any decision made, action or inaction taken by any party in reliance upon the information provided verbally or through the Internet, or any delays, inaccuracies, errors in, or omissions of information.

Your use of this webpage is conditioned to your acceptance of ALL our Disclosures and Terms of Service.